AIEU-Startupsabout 2 hours ago
Sightera raises €3M for AI drug platform
4 min read
Antwerp-based Sightera Biosciences closed a €3 million pre-Seed round led by Entourage, Anacura, and QBIC. The University of Antwerp spin-off will use the funding to expand its team, scale its AI-native drug discovery platform, and advance its lead molecular glue oncology programme toward preclinical candidate selection.
Level
Hype check
Tap to vote and see what everyone thinks.
